To assess the effects of pharmacological modulation of FGF21 on the astrocyte response after stroke, we subjected MCAO mice to intraperitoneal treatment with rhFGF21 at 12 h intervals starting after reperfusion and measured GFAP expression in the cortical areas adjacent to the infarcted region. This evidence concerns the gene FGF21 and stroke disorder.